Literature DB >> 3702855

Effects of amiloride and ouabain on contractile state, Ca and Na fluxes, and Na content in cultured chick heart cells.

D Kim, T W Smith.   

Abstract

Amiloride has been reported to reduce the positive inotropic and toxic actions of cardiac glycosides in patients as well as in experimental animals. To investigate the mechanism by which amiloride interacts with glycosides at the cellular level, we examined the effect of amiloride and ouabain on cellular Na content and uptake, Ca flux via Na-Ca exchange, and contractile state. Amiloride (1 mM) reduced cellular Na content by 16% (p less than 0.05) under normal conditions and by 45% in the presence of 1 mM ouabain compared to respective control values observed in the absence of amiloride. Amiloride (1 mM) reduced the initial rate of 45Ca uptake by 40% in ouabain (1 mM)-treated cells. This reduction of 45Ca uptake could be mimicked by lowering cellular Na content by 42%. Amiloride (1 mM) did not alter significantly the initial rate of 24Na uptake under normal conditions but reduced it by 32% in the presence of 3 microM ouabain. Amiloride (1 mM) produced a transient increase followed by a gradual decrease in the amplitude of cell motion over 60 min to 10% of control level. At other concentrations between 0.1 and 3 mM, amiloride produced negative inotropic effects only. Amiloride increased the concentration of ouabain needed to produce rhythm disturbances and contracture, and reduced Na-free contracture amplitude by 18%. These results are consistent with the view that amiloride antagonizes the arrhythmogenic effects of ouabain by inhibiting the glycoside-induced elevation in cellular Na content and, consequently, the increases in [Ca]i that occur via Na-dependent pathways. The reduced cellular Na content appears to be due to decreased Na influx via Na-H exchange.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3702855

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  8 in total

1.  Involvement of Na+/K+ pump in fine modulation of bursting activity of the snail Br neuron by 10 mT static magnetic field.

Authors:  Ljiljana Nikolić; Nataša Todorović; Joanna Zakrzewska; Marina Stanić; Snežana Rauš; Aleksandar Kalauzi; Branka Janać
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2012-04-26       Impact factor: 1.836

2.  Effects of amiloride in guinea-pig and rat left atrial contraction as affected by frequency of stimulation and [Ca2+]0-[Na+]0 ratio: role of Na+/Ca2+ exchange.

Authors:  G Cargnelli; S Bova; S Luciani
Journal:  Br J Pharmacol       Date:  1989-06       Impact factor: 8.739

3.  Mechanisms for cardiac depression induced by phorbol myristate acetate in working rat hearts.

Authors:  M Karmazyn; J E Watson; M P Moffat
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

4.  Opposite modulation of ouabain cardiotoxicity by hexamethyleneamiloride and phenylephrine.

Authors:  A Terzic; T Anagnostopoulos; S M Vogel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-05       Impact factor: 3.000

Review 5.  Oxygen free radicals and calcium homeostasis in the heart.

Authors:  M Kaneko; Y Matsumoto; H Hayashi; A Kobayashi; N Yamazaki
Journal:  Mol Cell Biochem       Date:  1994-10-12       Impact factor: 3.396

Review 6.  Oxygen free radicals and calcium homeostasis in the heart.

Authors:  M Kaneko; Y Matsumoto; H Hayashi; A Kobayashi; N Yamazaki
Journal:  Mol Cell Biochem       Date:  1994-06-15       Impact factor: 3.396

7.  Effects of N-chlorobenzyl analogues of amiloride on myocardial contractility, Na-Ca-exchange carrier and other cardiac enzymatic activities.

Authors:  M Floreani; M Tessari; P Debetto; S Luciani; F Carpenedo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-12       Impact factor: 3.000

8.  Use of Ion-Channel Modulating Agents to Study Cyanobacterial Na(+) - K(+) Fluxes.

Authors:  Francesco Pomati; Brendan P. Burns; Brett A. Neilan
Journal:  Biol Proced Online       Date:  2004-06-29       Impact factor: 3.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.